Özge Gümüşay

637 citations
42 papers · 350 indexed · 1 hit paper · h-index 11
Topics
Renal cell carcinoma treatment (7 papers)HER2/EGFR in Cancer Research (5 papers)Cancer Diagnosis and Treatment (5 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCA A Cancer Journal for Clinicians

In The Last Decade

Özge Gümüşay

36 papers receiving 345 citations

Hit Papers

Systemic therapy for hormone receptor‐positive/human epid...20232026202420252023255075

Peers

Özge Gümüşay
Comparison fields: 5 of 70
  • Oncology 164
  • Pulmonary and Respiratory Medicine 124
  • Molecular Biology 100
  • Cancer Research 78
  • Epidemiology 33
Replace K. Hoekman with:
K. Hoekman Netherlands
Daniel P. Petro United States
Maria Hassan Pakistan
Christa G.M. Gadellaa-van Hooijdonk Netherlands
Amy Krie United States
Eric Xueyu Chen Canada
Samia Melaabi France
Adekemi Taylor United States
Danmei Pang China
Christos Mikropoulos United Kingdom
Özge Gümüşay relative to K. Hoekman Netherlands K. Hoekman's profile →
Citations per field
00.5×10×15×20×23×
K. Hoekman · 1×
Citations per year

Countries citing papers authored by Özge Gümüşay

Since Specialization
Citations

This map shows the geographic impact of Özge Gümüşay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özge Gümüşay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özge Gümüşay more than expected).

Fields of papers citing papers by Özge Gümüşay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özge Gümüşay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özge Gümüşay. The network helps show where Özge Gümüşay may publish in the future.

Co-authorship network of co-authors of Özge Gümüşay

This figure shows the co-authorship network connecting the top 25 collaborators of Özge Gümüşay. A scholar is included among the top collaborators of Özge Gümüşay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özge Gümüşay. Özge Gümüşay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancerbreakdown →
96
2 1
3 3
4 4
5 13
6 17
7 3
8 3
9 12
10 1
11 1
12 4
13 4
14 3
15 15
16 5
17 5
18 3
19 1
20 23

About Özge Gümüşay

Özge Gümüşay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 42 papers that have together received 350 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (164 citations), Cancer Research (78 citations) and Pulmonary and Respiratory Medicine (124 citations). Özge Gümüşay has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Hope S. Rugo, Laura A. Huppert, Bülent Çetin, Damé Idossa, Ahmet Özet, Süleyman Buyukberber, İpek Işık Gönül, Aytuğ Üner, Mustafa Beneklı and Uğur Çoşkun. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and CA A Cancer Journal for Clinicians.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026